This resulted in the diagnosis of Lynch syndrome (MSH2 mutation) in one participant and the detection of two participants with gene variants of unknown clinical significance in the MLH1 gene and the MSH6 gene, appointed to a 2 yearly and 5 yearly surveillance interval, respectively. This evidence concerns the gene MLH1 and Lynch syndrome.